Genfit S.A. (GNFT.PA)
EUR 3.77
(5.72%)
EUR 3.77
(5.72%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 28.22 Million EUR | 41.49% |
| 2022 | 19.94 Million EUR | -75.04% |
| 2021 | 79.9 Million EUR | 14093.25% |
| 2020 | 563 Thousand EUR | -98.16% |
| 2019 | 30.66 Million EUR | 1817.76% |
| 2018 | -1.78 Million EUR | 15.44% |
| 2017 | -2.11 Million EUR | -24.1% |
| 2016 | -1.7 Million EUR | -21.15% |
| 2015 | -1.4 Million EUR | -768.25% |
| 2014 | 210.1 Thousand EUR | -65.35% |
| 2013 | 606.4 Thousand EUR | 27.07% |
| 2012 | 477.2 Thousand EUR | -49.73% |
| 2011 | 949.3 Thousand EUR | -60.26% |
| 2010 | 2.38 Million EUR | -43.21% |
| 2009 | 4.2 Million EUR | -40.06% |
| 2008 | 7.01 Million EUR | -6.09% |
| 2007 | 7.47 Million EUR | -10.69% |
| 2006 | 8.36 Million EUR | -26.97% |
| 2005 | 11.45 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 60.23 Million EUR | 0.0% |
| 2023 Q3 | 2.81 Million EUR | -81.35% |
| 2023 FY | 28.22 Million EUR | 41.49% |
| 2023 Q2 | 15.11 Million EUR | 0.0% |
| 2023 Q4 | 17.08 Million EUR | 506.21% |
| 2022 Q2 | 12.14 Million EUR | 0.0% |
| 2022 Q3 | 5.31 Million EUR | -56.27% |
| 2022 FY | 19.94 Million EUR | -75.04% |
| 2022 Q4 | 6.09 Million EUR | 14.78% |
| 2021 Q2 | 3.25 Million EUR | 0.0% |
| 2021 Q4 | 82.1 Million EUR | 0.0% |
| 2021 FY | 79.9 Million EUR | 14093.25% |
| 2020 Q4 | 2.81 Million EUR | 0.0% |
| 2020 FY | 563 Thousand EUR | -98.16% |
| 2020 Q2 | 5.86 Million EUR | 0.0% |
| 2019 Q4 | 33.61 Million EUR | 0.0% |
| 2019 FY | 30.66 Million EUR | 1817.76% |
| 2019 Q2 | 5.35 Million EUR | -30.57% |
| 2019 Q1 | 7.7 Million EUR | 214.94% |
| 2018 FY | -1.78 Million EUR | 15.44% |
| 2018 Q4 | 2.44 Million EUR | 0.0% |
| 2018 Q2 | 4.58 Million EUR | 232.67% |
| 2018 Q1 | 1.37 Million EUR | -22.33% |
| 2017 Q4 | 1.77 Million EUR | 0.0% |
| 2017 FY | -2.11 Million EUR | -24.1% |
| 2017 Q1 | -527.75 Thousand EUR | -120.91% |
| 2017 Q2 | 4.06 Million EUR | 869.64% |
| 2016 FY | -1.7 Million EUR | -21.15% |
| 2016 Q2 | 3.08 Million EUR | 824.69% |
| 2016 Q1 | -425.25 Thousand EUR | -130.6% |
| 2016 Q4 | 2.52 Million EUR | 0.0% |
| 2015 FY | -1.4 Million EUR | -768.25% |
| 2015 Q3 | -351 Thousand EUR | -118.72% |
| 2015 Q2 | 1.87 Million EUR | 634.26% |
| 2015 Q1 | -351 Thousand EUR | -114.92% |
| 2015 Q4 | 1.38 Million EUR | 495.94% |
| 2014 FY | 210.1 Thousand EUR | -65.35% |
| 2014 Q1 | 52.52 Thousand EUR | 107.64% |
| 2014 Q3 | 52.52 Thousand EUR | -98.14% |
| 2014 Q2 | 2.82 Million EUR | 5284.1% |
| 2014 Q4 | 2.35 Million EUR | 4377.87% |
| 2013 Q3 | 151.6 Thousand EUR | 210.66% |
| 2013 FY | 606.4 Thousand EUR | 27.07% |
| 2013 Q4 | -687.6 Thousand EUR | -553.56% |
| 2013 Q2 | 48.8 Thousand EUR | -67.81% |
| 2013 Q1 | 151.6 Thousand EUR | 0.0% |
| 2012 Q1 | 119.3 Thousand EUR | 0.0% |
| 2012 Q4 | 151.6 Thousand EUR | 27.07% |
| 2012 FY | 477.2 Thousand EUR | -49.73% |
| 2012 Q2 | 119.3 Thousand EUR | 0.0% |
| 2012 Q3 | 119.3 Thousand EUR | 0.0% |
| 2011 Q3 | 237.32 Thousand EUR | 0.0% |
| 2011 Q1 | 237.32 Thousand EUR | 0.0% |
| 2011 Q2 | 237.32 Thousand EUR | 0.0% |
| 2011 Q4 | 119.3 Thousand EUR | -49.73% |
| 2011 FY | 949.3 Thousand EUR | -60.26% |
| 2010 Q1 | 597.12 Thousand EUR | 0.0% |
| 2010 Q2 | 597.12 Thousand EUR | 0.0% |
| 2010 Q3 | 597.12 Thousand EUR | 0.0% |
| 2010 Q4 | 237.32 Thousand EUR | -60.26% |
| 2010 FY | 2.38 Million EUR | -43.21% |
| 2009 FY | 4.2 Million EUR | -40.06% |
| 2009 Q4 | 597.12 Thousand EUR | -43.21% |
| 2009 Q3 | 1.05 Million EUR | 0.0% |
| 2009 Q2 | 1.05 Million EUR | 0.0% |
| 2009 Q1 | 1.05 Million EUR | 0.0% |
| 2008 Q2 | 1.75 Million EUR | 0.0% |
| 2008 Q4 | 1.05 Million EUR | -40.06% |
| 2008 Q3 | 1.75 Million EUR | 0.0% |
| 2008 Q1 | 1.75 Million EUR | 0.0% |
| 2008 FY | 7.01 Million EUR | -6.09% |
| 2007 Q2 | 1.86 Million EUR | 0.0% |
| 2007 Q3 | 1.86 Million EUR | 0.0% |
| 2007 Q4 | 1.75 Million EUR | -6.09% |
| 2007 FY | 7.47 Million EUR | -10.69% |
| 2007 Q1 | 1.86 Million EUR | 0.0% |
| 2006 Q2 | 2.09 Million EUR | 0.0% |
| 2006 Q4 | 1.86 Million EUR | -10.69% |
| 2006 FY | 8.36 Million EUR | -26.97% |
| 2006 Q1 | 2.09 Million EUR | 0.0% |
| 2006 Q3 | 2.09 Million EUR | 0.0% |
| 2005 Q3 | 2.86 Million EUR | 0.0% |
| 2005 FY | 11.45 Million EUR | 0.0% |
| 2005 Q2 | 2.86 Million EUR | 0.0% |
| 2005 Q1 | 2.86 Million EUR | 0.0% |
| 2005 Q4 | 2.09 Million EUR | -26.97% |
| 2004 Q4 | 2.86 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ABIONYX Pharma SA | 618 Thousand EUR | -4466.99% |
| ABIVAX Société Anonyme | 3.91 Million EUR | -621.104% |
| Adocia SA | 1.38 Million EUR | -1937.834% |
| Aelis Farma SA | 12.35 Million EUR | -128.386% |
| Biophytis S.A. | -803 Thousand EUR | 3614.819% |
| Advicenne S.A. | 1.42 Million EUR | -1879.243% |
| genOway Société anonyme | 20.1 Million EUR | -40.415% |
| IntegraGen SA | 5.01 Million EUR | -462.424% |
| Medesis Pharma S.A. | -2.66 Million EUR | 1159.154% |
| Neovacs S.A. | 29.31 Thousand EUR | -96181.64% |
| NFL Biosciences SA | -56.06 Thousand EUR | 50442.466% |
| Plant Advanced Technologies SA | 2.15 Million EUR | -1210.966% |
| Quantum Genomics Société Anonyme | -1.41 Million EUR | 2088.601% |
| Sensorion SA | 3.78 Million EUR | -645.117% |
| Theranexus Société Anonyme | -4.63 Million EUR | 708.448% |
| TME Pharma N.V. | -127 Thousand EUR | 22323.622% |
| Valbiotis SA | 2.66 Million EUR | -957.871% |
| TheraVet SA | -530.79 Thousand EUR | 5417.297% |
| Valerio Therapeutics Société anonyme | 1.26 Million EUR | -2127.624% |
| DBV Technologies S.A. | 4.15 Million EUR | -578.528% |
| GeNeuro SA | -293.8 Thousand EUR | 9706.535% |
| Innate Pharma S.A. | -4.12 Million EUR | 784.882% |
| Inventiva S.A. | 17.5 Million EUR | -61.28% |
| MaaT Pharma SA | 1.65 Million EUR | -1605.378% |
| MedinCell S.A. | 9.28 Million EUR | -203.876% |
| Nanobiotix S.A. | 36.2 Million EUR | 22.05% |
| OSE Immunotherapeutics SA | 2.22 Million EUR | -1167.355% |
| Poxel S.A. | 1000.00 EUR | -2822300.0% |
| GenSight Biologics S.A. | 3 Million EUR | -840.8% |
| Transgene SA | -28.4 Million EUR | 199.366% |
| Valneva SE | 52.83 Million EUR | 46.583% |